Review




Structured Review

Ribobio co me-rip m6a transcriptome profiling kit
Me Rip M6a Transcriptome Profiling Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+profiles/me+rip+m6a+transcriptome+profiling+kit/pm36319624-114-5-10
Average 90 stars, based on 1 article reviews
me-rip m6a transcriptome profiling kit - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Modification:

Article Title: Methyltransferase-like 7B participates in bladder cancer via ACSL3 m 6 A modification in a ferroptosis manner
Article Snippet: .. m 6 A modification on ACSL3 was validated by MeRIP-RT-qPCR assay referred to [ ] using m6A Transcriptome Profiling Kit (RiboBio Co. Ltd., Guangzhou, China). ..

Article Title: Methyltransferase-like 7B participates in bladder cancer via ACSL3 m 6 A modification in a ferroptosis manner.
Article Snippet: .. m6A modification on ACSL3 was validated by MeRIPRT-qPCR assay referred to [20] using m6A Transcriptome Profiling Kit (RiboBio Co. Ltd., Guangzhou, China). ..

other:

Article Title: Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1.
Article Snippet: Me-RIP was performed using the Me-RIP m6A transcriptome profiling kit (Ribobio, Guangzhou).

Article Title: The METTL3-m 6 A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma.
Article Snippet: The upregulation of methyltransferase-like 3 (METTL3) has been associated with the progression of esophageal cancer.. However, METTL3-induced N6-methyladenosine (m6A) alterations on the downstream target mRNAs in esophageal squamous cell carcinoma (ESCC) are not yet fully understood.. Our study revealed that silencing METTL3 resulted in a significant decrease in ESCC cell proliferation and metastasis in vitro and in vivo.

Article Title: METTL3 knockdown suppresses RA-FLS activation through m 6 A-YTHDC2-mediated regulation of AMIGO2.
Article Snippet: The dysregulation of N6-methyladenosine (m6A) on mRNAs is involved in the pathogenesis of rheumatoid arthritis (RA).. Methyltransferase-like 3 (METTL3), serving as a central m6A methyltransferase, is highly expressed in macrophages, synovial tissues and RA fibroblast-like synoviocytes (RA-FLS) of RA patients.. However, METTL3-mediated m6A modification on target mRNAs and the molecular mechanisms involved in RA-FLS remain poorly defined.

Article Title: FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
Article Snippet: Funding information Ningbo Municipal Natural Science Foundation Project, Grant/Award Number: 2022J036 Abstract Early treatment of retinoblastoma (RB) has significantly improved clinical outcomes.. N6‐ methyladenosine (m6A) methylation is crucial for cancer progression.. Thus, we investigated the role of FTO‐dependent demethylation in RB and its underlying mechanisms.



Similar Products

86
Novogene transcriptomic profiling
Transcriptomic Profiling, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+profiles/profiling+transcriptomic/pm42234763-323-0-19
Average 86 stars, based on 1 article reviews
transcriptomic profiling - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
10X Genomics 760 spatial transcriptomic profiling
760 Spatial Transcriptomic Profiling, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+profiles/data+spatial+transcriptomic/pm42167485-330-12-20
Average 86 stars, based on 1 article reviews
760 spatial transcriptomic profiling - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Medicago leaf layer based transcriptome profiling 33
Leaf Layer Based Transcriptome Profiling 33, supplied by Medicago, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+profiles/33+based+layer+leaf+profiling+transcriptome/pm41889343-443-0-11
Average 86 stars, based on 1 article reviews
leaf layer based transcriptome profiling 33 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Human Protein Atlas transcriptomic profiles
(a-d) t-SNE performed on (a) PBMC immune frequencies, (b) PBMC gene expression, (c) immune frequencies and gene expression combined, and (d) plasma proteomics. (e) Clustering of <t>transcriptomic</t> data from our study and the Human Protein Atlas. (f) Distribution of Euclidean distance in transcriptomic profiles between collected samples (i) from the same participant within the first year (visit 1-4), (ii) from the same participant between year 1 and year 2 (visit 5-6), and (iii) from different participants. Wilcoxon tests were used for statistical analysis (ns, not significant; ****, P < 0.0001). (g) Euclidean distance between each transcriptomic profile from the last visit and the sample collected during the first year, divided into (i) pairs of samples from the same individual (light blue) and (ii) pairs of samples from different participants (red). (h) Distribution of intraclass correlation coefficient of immune cell profiling, transcriptomic and plasma proteomics. (i) Intraclass correlation coefficient of all 53 immune populations. (j) Intra- and inter-individual coefficients of variation of gene expression. (k) Examples of genes, immune populations and proteins showing individual expression profiles. Samples are colored according to their expression levels at visit 1 (orange: 0-25%, green: 25–50%, blue: 50–75%, purple: 75–100%). The highlighted dots indicate the median level of the corresponding group at that visit.
Transcriptomic Profiles, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+profiles/profiles+transcriptomic/bio_rxiv__64898__2026__03__21__713378-218-4-9
Average 86 stars, based on 1 article reviews
transcriptomic profiles - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Hua Da Inc transcriptomic profiling
(a-d) t-SNE performed on (a) PBMC immune frequencies, (b) PBMC gene expression, (c) immune frequencies and gene expression combined, and (d) plasma proteomics. (e) Clustering of <t>transcriptomic</t> data from our study and the Human Protein Atlas. (f) Distribution of Euclidean distance in transcriptomic profiles between collected samples (i) from the same participant within the first year (visit 1-4), (ii) from the same participant between year 1 and year 2 (visit 5-6), and (iii) from different participants. Wilcoxon tests were used for statistical analysis (ns, not significant; ****, P < 0.0001). (g) Euclidean distance between each transcriptomic profile from the last visit and the sample collected during the first year, divided into (i) pairs of samples from the same individual (light blue) and (ii) pairs of samples from different participants (red). (h) Distribution of intraclass correlation coefficient of immune cell profiling, transcriptomic and plasma proteomics. (i) Intraclass correlation coefficient of all 53 immune populations. (j) Intra- and inter-individual coefficients of variation of gene expression. (k) Examples of genes, immune populations and proteins showing individual expression profiles. Samples are colored according to their expression levels at visit 1 (orange: 0-25%, green: 25–50%, blue: 50–75%, purple: 75–100%). The highlighted dots indicate the median level of the corresponding group at that visit.
Transcriptomic Profiling, supplied by Hua Da Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+profiles/profiling+transcriptomic/pmc13031519-66-8-11
Average 86 stars, based on 1 article reviews
transcriptomic profiling - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Galbraith Laboratories Inc transcriptomic profiling
(a-d) t-SNE performed on (a) PBMC immune frequencies, (b) PBMC gene expression, (c) immune frequencies and gene expression combined, and (d) plasma proteomics. (e) Clustering of <t>transcriptomic</t> data from our study and the Human Protein Atlas. (f) Distribution of Euclidean distance in transcriptomic profiles between collected samples (i) from the same participant within the first year (visit 1-4), (ii) from the same participant between year 1 and year 2 (visit 5-6), and (iii) from different participants. Wilcoxon tests were used for statistical analysis (ns, not significant; ****, P < 0.0001). (g) Euclidean distance between each transcriptomic profile from the last visit and the sample collected during the first year, divided into (i) pairs of samples from the same individual (light blue) and (ii) pairs of samples from different participants (red). (h) Distribution of intraclass correlation coefficient of immune cell profiling, transcriptomic and plasma proteomics. (i) Intraclass correlation coefficient of all 53 immune populations. (j) Intra- and inter-individual coefficients of variation of gene expression. (k) Examples of genes, immune populations and proteins showing individual expression profiles. Samples are colored according to their expression levels at visit 1 (orange: 0-25%, green: 25–50%, blue: 50–75%, purple: 75–100%). The highlighted dots indicate the median level of the corresponding group at that visit.
Transcriptomic Profiling, supplied by Galbraith Laboratories Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+profiles/profiling+transcriptomic/pm41702206-202-22-10
Average 86 stars, based on 1 article reviews
transcriptomic profiling - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


(a-d) t-SNE performed on (a) PBMC immune frequencies, (b) PBMC gene expression, (c) immune frequencies and gene expression combined, and (d) plasma proteomics. (e) Clustering of transcriptomic data from our study and the Human Protein Atlas. (f) Distribution of Euclidean distance in transcriptomic profiles between collected samples (i) from the same participant within the first year (visit 1-4), (ii) from the same participant between year 1 and year 2 (visit 5-6), and (iii) from different participants. Wilcoxon tests were used for statistical analysis (ns, not significant; ****, P < 0.0001). (g) Euclidean distance between each transcriptomic profile from the last visit and the sample collected during the first year, divided into (i) pairs of samples from the same individual (light blue) and (ii) pairs of samples from different participants (red). (h) Distribution of intraclass correlation coefficient of immune cell profiling, transcriptomic and plasma proteomics. (i) Intraclass correlation coefficient of all 53 immune populations. (j) Intra- and inter-individual coefficients of variation of gene expression. (k) Examples of genes, immune populations and proteins showing individual expression profiles. Samples are colored according to their expression levels at visit 1 (orange: 0-25%, green: 25–50%, blue: 50–75%, purple: 75–100%). The highlighted dots indicate the median level of the corresponding group at that visit.

Journal: bioRxiv

Article Title: Systems-level longitudinal immune profiling reveals individualized immunotypes and genetic associations

doi: 10.64898/2026.03.21.713378

Figure Lengend Snippet: (a-d) t-SNE performed on (a) PBMC immune frequencies, (b) PBMC gene expression, (c) immune frequencies and gene expression combined, and (d) plasma proteomics. (e) Clustering of transcriptomic data from our study and the Human Protein Atlas. (f) Distribution of Euclidean distance in transcriptomic profiles between collected samples (i) from the same participant within the first year (visit 1-4), (ii) from the same participant between year 1 and year 2 (visit 5-6), and (iii) from different participants. Wilcoxon tests were used for statistical analysis (ns, not significant; ****, P < 0.0001). (g) Euclidean distance between each transcriptomic profile from the last visit and the sample collected during the first year, divided into (i) pairs of samples from the same individual (light blue) and (ii) pairs of samples from different participants (red). (h) Distribution of intraclass correlation coefficient of immune cell profiling, transcriptomic and plasma proteomics. (i) Intraclass correlation coefficient of all 53 immune populations. (j) Intra- and inter-individual coefficients of variation of gene expression. (k) Examples of genes, immune populations and proteins showing individual expression profiles. Samples are colored according to their expression levels at visit 1 (orange: 0-25%, green: 25–50%, blue: 50–75%, purple: 75–100%). The highlighted dots indicate the median level of the corresponding group at that visit.

Article Snippet: Moreover, we downloaded the transcriptomic profiles available from the Human Protein Atlas ( https://www.proteinatlas.org/humanproteome/blood ) and used them to verify the expression patterns of key genes across cell types.

Techniques: Gene Expression, Clinical Proteomics, Expressing

(a) t-SNE sample clustering based on transcriptomic profiles of genes in the PBMC association network. (b) Immune frequencies patterns across the three sample clusters. (c) Distribution of (top) innate immune cell frequencies and (bottom) CD4:CD8 ratio across the three clusters. (d) Immune frequencies of the modules in the PBMC network, divided by sample clusters. (e) Number of up- and down-regulated genes in each module (FDR<0.05) obtained from differential expression analysis between each cluster and the remaining two. (f-h) t-SNE clustering colored based on CD4:CD8+ T cells ratio, and immune frequencies of the B cells, cytotoxic and myeloid modules. (j) (Top) CRP levels of participant P3920. (Bottom) Sample clusters of participants across visits; highlighted in black are the samples from participant P3920. (k) Pattern of clinical variables across the three clusters. (l) Patterns of the 30 proteins with the most significant up-regulation in any of the three clusters. SBP, systolic blood pressure; DBP, diastolic blood pressure; TNT, troponin T; CRP, C-reactive protein; HDL, high density lipoprotein; ALAT, alanine aminotransferase; GGT, gamma-glutamyl transferase. P-values are calculated by Wilcoxon tests in c-d; ns, not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Journal: bioRxiv

Article Title: Systems-level longitudinal immune profiling reveals individualized immunotypes and genetic associations

doi: 10.64898/2026.03.21.713378

Figure Lengend Snippet: (a) t-SNE sample clustering based on transcriptomic profiles of genes in the PBMC association network. (b) Immune frequencies patterns across the three sample clusters. (c) Distribution of (top) innate immune cell frequencies and (bottom) CD4:CD8 ratio across the three clusters. (d) Immune frequencies of the modules in the PBMC network, divided by sample clusters. (e) Number of up- and down-regulated genes in each module (FDR<0.05) obtained from differential expression analysis between each cluster and the remaining two. (f-h) t-SNE clustering colored based on CD4:CD8+ T cells ratio, and immune frequencies of the B cells, cytotoxic and myeloid modules. (j) (Top) CRP levels of participant P3920. (Bottom) Sample clusters of participants across visits; highlighted in black are the samples from participant P3920. (k) Pattern of clinical variables across the three clusters. (l) Patterns of the 30 proteins with the most significant up-regulation in any of the three clusters. SBP, systolic blood pressure; DBP, diastolic blood pressure; TNT, troponin T; CRP, C-reactive protein; HDL, high density lipoprotein; ALAT, alanine aminotransferase; GGT, gamma-glutamyl transferase. P-values are calculated by Wilcoxon tests in c-d; ns, not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Article Snippet: Moreover, we downloaded the transcriptomic profiles available from the Human Protein Atlas ( https://www.proteinatlas.org/humanproteome/blood ) and used them to verify the expression patterns of key genes across cell types.

Techniques: Quantitative Proteomics